A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women

Menopause

Volumn 16, Issue 2, 2009, Pages 247-256

  Gast, Michael J ^a   Freedman, Murray A ^b   Vieweg, Alberta J ^a   De Melo, Nilson R ^c   Girão, Manoel J B C ^d   Zinaman, Michael J ^e,f  

^a PFIZER INC   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c Instituto de Bem Estar e Saúde   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

^f NONE   (United States)

Author keywords

Conjugated estrogens; Dyspareunia; Hormone therapy; Premarin; Quality of life; Sexual function

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PLACEBO;

ABDOMINAL PAIN; ACUTE CHOLECYSTITIS; ADULT; AGED; ARTICLE; BACKACHE; BONE PAIN; CHEST TIGHTNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPAREUNIA; FEMALE; HUMAN; LEUKORRHEA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MASTALGIA; MORBIDITY; MULTIPLE CYCLE TREATMENT; ORGASM; PNEUMONIA; POSTMENOPAUSE; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; STRUCTURED QUESTIONNAIRE; THORAX PAIN; TREATMENT RESPONSE; VAGINITIS;

EID: 67649345969     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318184c440     Document Type: Article

References (31)

1. Blumel JE, Castelo-Branco C, Binfa L, et al. Quality of life after the menopause: a population study. Maturitas 2000;34:17-23.
2. Greendale GA, Lee NP, Arriola ER. The menopause. Lancet 1999; 353:571-580.
3. Marwick C. Survey says patients expect little physician help on sex. JAMA 1999;281:2173-2174.
4. Castelo-Branco C, Blumel JE, Araya H, et al. Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy. J Obstet Gynaecol 2003;23: 426-430.
5. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001;76: 456-460.
6. Gott M, Hinchliff S. How important is sex in later life? The views of older people. Soc Sci Med 2003;56:1617-1628.
7. Basson R. Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet Gynecol 2001;98:350-353.
8. Basson R, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000;163:888-893.
9. Freedman MA. Quality of life and menopause: the role of estrogen. J Womens Health (Larchmt) 2002;11:703-718.
10. Modelska K, Litwack S, Ewing SK, Yaffe K. Endogenous estrogen levels affect sexual function in elderly post-menopausal women. Maturitas 2004;49:124-133.
11. Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990;75:26S-30S.
12. Manonai J, Theppisai U, Suthutvoravut S, Udomsubpayakul U, Chittacharoen A. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study. J Obstet Gynaecol Res 2001;27:255-260.
13. Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arch Sex Behav 1994;23:627-643.
14. McCoy NL, Matyas JR. Oral contraceptives and sexuality in university women. Arch Sex Behav 1996;25:73-90.
15. Hunter MS. The Women's Health Questionnaire (WHQ): frequently asked questions (FAQ). Health Qual Life Outcomes 2003;1:41.
16. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065-1079.
17. Alexander JL, Kotz K, Dennerstein L, Kutner SJ, Wallen K, Notelovitz M. The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials. Menopause 2004; 11:749-765.
18. Baracat EC, Barbosa IC, Giordano MG, et al. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability. Climacteric 2002;5:60-69.
19. Barrett-Connor E, Young R, Notelovitz M, et al. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 1999;44:1012-1020.
20. Kovalevsky G. Female sexual dysfunction and use of hormone therapy in postmenopausal women. Semin Reprod Med 2005;23:180-187.
21. Pinkerton JV, Shifren JL, La Valleur J, Rosen A, Roesinger M, Siddhanti S. Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women. Menopause 2003;10:45-52.
22. Palacios S, Castelo-Branco C, Cancelo MJ, Vazquez F. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Maturitas 2005;50:98-104.
23. Dessole S, Rubattu G, Ambrosini G, et al. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause 2004;11:49-56.
24. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722-727.
25. Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 1997;71:73-180.
26. Nathorst-Boos J, Wiklund I, Mattsson LA, Sandin K, von Schoultz B. Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women. Acta Obstet Gynecol Scand 1993;72:656-660.
27. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993; 168:824-830.
28. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-1854.
29. Hartmann U, Philippsohn S, Heiser K, Ruffer-Hesse C. Low sexual desire in midlife and older women: personality factors, psychosocial development, present sexuality. Menopause 2004; 11:726-740.
30. Penteado SR, Fonseca AM, Bagnoli VR, Assis JS, Pinotti JA. Sexuality in healthy postmenopausal women. Climacteric 2003;6:321-329.
31. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544.